by U.S. Medicine
Pharmacists and other healthcare professionals understand the importance of clearly identifying medications requiring special handling, such as those covered by USP <800> and that the safety of staff and patients is at stake.
by U.S. Medicine
Patients diagnosed with antimitochondrial antibody (AMA)-negative primary biliary cholangitis (PBC) have clinical and histopathological findings consistent with PBC but without positive AMA.
by Annette Boyle
Active-duty servicemembers face well known and quantified risk for alcohol misuse. Consequently, many return from combat to military bases, where they receive screening and have ready access to behavioral health.
by U.S. Medicine
While it is recognized that patients with nonalcoholic fatty liver disease who also have Type 2 diabetes mellitus (DM) have a high risk of progression to hepatocellular carcinoma. Exactly what causes the higher risks remain unclear, however, according to a new study.
by U.S. Medicine
For a patient with cirrhosis, the five-year risk of developing hepatocellular carcinoma (HCC), a highly lethal cancer with a significant increasing incidence and mortality, might be as high as 30%.